ADRO becomes KDNY effective 10/5/20—following 1:5 reverse split tomorrow: https://www.globenewswire.com/news-release/2020/10/01/2102576/0/en/Aduro-Biotech-Stockholders-Approve-Merger-Agreement-with-Chinook-Therapeutics.html